The Malaysian insurance and takaful industry is bracing for sustained double-digit growth in medical claims over the coming months, following a sharp 12.28 per cent spike in claims inflation during 2025. Industry bodies have flagged that this acceleration, driven primarily by an expanding pool of insured patients turning to private healthcare facilities, poses significant challenges to the long-term sustainability of medical coverage schemes across the region.
Total medical claims disbursed by insurers and takaful operators climbed to RM13.5 billion last year, representing a 10.7 per cent increase from RM12.2 billion in 2024, according to findings released jointly by the Life Insurance Association of Malaysia (LIAM), Malaysian Takaful Association (MTA), and General Insurance Association of Malaysia (PIAM). The three bodies, which collectively represent the vast majority of medical and health insurance providers in Malaysia, presented their analysis through the Malaysia Medical Claims Inflation Report 2025, which offers a comprehensive breakdown of where money is being spent and why costs are accelerating at such a rapid pace.
The decomposition of the 12.28 per cent inflation rate reveals a telling story about consumer behaviour and healthcare utilisation patterns. Of this total, 11.22 percentage points stemmed directly from an increase in the volume of claims being filed—meaning more insured individuals are accessing healthcare services—while the remaining 1.06 percentage points reflected genuine cost escalations within the healthcare system itself. This distinction matters significantly for policymakers and insurers attempting to distinguish between legitimate healthcare inflation and utilisation-driven growth, as each requires different policy responses.
A striking feature of the claims landscape is the divergent performance between public and private hospital segments. Public hospitals, which account for only nine per cent of all insured claims, actually recorded a 14 per cent contraction in claims costs year-on-year, suggesting that either fewer insured patients are accessing these facilities or that public sector cost-control measures are proving effective. Conversely, private hospital claims surged 5.89 per cent, while day-care and outpatient procedures in private settings rose 2.3 per cent. This compositional shift toward private healthcare among the insured population appears to be a principal driver of overall claims acceleration, reflecting both the growing prevalence of private insurance schemes and changing patient preferences.
Mark O'Dell, chief executive officer of LIAM, contextualised these findings within broader healthcare system trends identified by the World Bank in its assessment of Malaysia's Medical and Health Insurance/Takaful sector. The World Bank analysis identified healthcare utilisation and service intensity—essentially, how frequently people use medical services and how complex or resource-intensive those services are—as fundamental drivers of escalating claims costs. O'Dell stressed that addressing this trajectory demands coordinated action spanning government regulators, private and public healthcare providers, insurance companies, takaful operators, and the consumer base itself, each playing a defined role in rebuilding cost discipline without compromising access to quality care.
The urgency of this challenge becomes apparent when historical trends are examined. Mohd Radzuan Mohamed, chief executive of MTA, highlighted that average annual medical claims inflation reached 13.63 per cent across the 2023-2025 period, more than 70 per cent higher than the approximately eight per cent annual growth observed between 2013 and 2018. This acceleration over the past seven years reflects a fundamental shift in healthcare cost dynamics within Malaysia's insured population and raises legitimate questions about fund adequacy and premium sustainability if current trajectories persist unchanged.
The implications for Malaysian consumers are considerable. As claims costs continue climbing faster than historical norms, insurers face pressure to either increase premium rates, narrow coverage scopes, raise co-insurance requirements, or implement stricter claim validation procedures. Takaful participants face similar pressures within their mutual models. These adjustments, while potentially necessary to maintain fund solvency, may price out middle-income workers or discourage younger, healthier individuals from enrolling, potentially creating adverse selection spirals that further destabilise the sector.
Chua Kim Soon, chief executive of PIAM, underscored that managing claims growth demands unified stakeholder engagement to enforce pricing transparency, root out fraud and abuse, and ensure that healthcare delivery remains efficient. The general insurance body emphasised that claims control cannot be achieved through insurer action alone; it requires healthcare providers to adopt efficient practices and transparent billing, and consumers to make thoughtful care-seeking decisions.
Industry participants are banking on several interventions to moderate claims growth trajectories. Enhanced fraud detection and abuse prevention programmes, combined with more rigorous cost transparency across provider networks, could reduce wasteful expenditure. The adoption of Diagnosis Related Group-based billing systems, which tie provider payments to standardised treatment protocols rather than fee-for-service metrics, may incentivise efficiency. The MediAsas plan—a government-supported initiative designed to provide affordable medical coverage—offers another avenue for channelling utilisation toward cost-effective public and private providers, potentially relieving pressure on premium-driven schemes.
The insurance and takaful industry has publicly committed to working alongside policymakers, healthcare regulators, and providers to construct a healthcare ecosystem characterised by affordability, transparency, operational efficiency, and long-term financial sustainability. This commitment reflects recognition that uncontrolled claims inflation ultimately harms all stakeholders: consumers face higher premiums, providers confront payment pressures, and insurers struggle with profitability. Yet translating this collective aspiration into concrete policy and operational changes remains the genuine challenge ahead. The coming months will test whether stakeholders can move beyond joint statements to implement the kind of systemic reforms necessary to bend the cost curve downward while preserving access to quality medical protection for Malaysia's growing insured population.
